Login
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc.

2020gene.com

What Do They Do?

Develops and sells AI-powered laboratory blood tests for early cancer detection and chronic disease prevention, and provides laboratory access for diagnostics startups.

How Do They Make Money?

Customers pay for laboratory blood tests and services, including access to its shared laboratory; the filing describes revenue when customers receive the promised goods or services but does not say when payment is due.

FY2025 revenue by product or service revenue
SegmentShareRevenue
BioCheck
7.4%
OneTest
88%
CLIAx
4.4%

Who Are Their Customers?

The company sells tests to firefighters, employers, individual consumers, veterans, fire departments, and physician practices. It markets directly to consumers online and through retail pharmacies, and serves fire departments, employers, and other organizations.

Do Revenues Turn Into Profits?

No. It lost $3.7M in FY2025.

Operating income, FY2025
−163% of revenue
▲ +41% (Loss) vs FY2024 (−$5.7M, −324%)
Net income, FY2025
−183% of revenue
▲ +33% (Loss) vs FY2024 (−$5.6M, −317%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q2 FY2026, the three months to Jun 30, 2026
Revenue
▲ +37%
vs $535.1K in Q2 FY2025
Net income
▼ −79% (Loss)
vs −$840.9K in Q2 FY2025
OneTest share of revenue vs 88.4% in Q2 FY2025
  • Sep 3, 2026 Nasdaq cited bid-price and stockholders’ equity listing deficiencies The company has time to submit a plan for the equity requirement and a compliance period for the bid-price rule; failure to regain compliance could lead to delisting.
Revenue over time
BioCheck OneTest CLIAx
$2.5M$1.3M$0

Who Do They Compete With?

Competes with Grail, Illumina, Thrive, and Exact Sciences

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support